N@N

Law Office of Brodsky & Smith, LLC Announces Investigation of Genoptix, Inc.

_{//health-fitness.news-articles.net/content/2011/ .. llc-announces-investigation-of-genoptix-inc.html}
^{Published in Health and Fitness on Monday, January 24th 2011 at 20:20 GMT by Market Wire}  

BALA CYNWYD, Pa.--([ BUSINESS WIRE ])--Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Genoptix, Inc. (aGenoptixa or the aCompanya) (Nasdaq: GXDX) relating to the proposed acquisition by Novartis AG (NYSE: NVS) in a transaction valued at approximately $470 million.

Under the terms of the offer, Genoptix shareholders would receive cash of $25.00 for each share of Genoptix stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law. The transaction appears to be unfair, in part, given the 52 week high trading high for the Companya™s stock was $38.79 a share. Additionally, at least one analyst has set a target price of $28.00 for Genoptix stock.

If you own shares of Genoptix and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at [ investorrelations@brodsky-smith.com ], or by calling toll free 877-LEGAL-90.